http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109270283-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6084941b94f1d7a9788e9a5b73026490 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76 |
filingDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd82dd0fcf07dc2f31485dd9d7db849b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415efc727f126b904f50d408d52c7ced http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b362d90c4a29a764eba05f63731b0506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b38fe8473cda6a4584ee5088d0719a95 |
publicationDate | 2019-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-109270283-A |
titleOfInvention | A stable tumor marker composite control product |
abstract | The invention discloses a stable tumor marker composite control product, comprising a matrix liquid and a tumor marker positive substance, wherein the matrix liquid is obtained by adding anhydrous calcium chloride solution to normal human plasma, and A protective agent and a preservative are added thereto; and the tumor marker comprises 20 tumor marker positive substances. The quality control product of the invention has a high degree of compounding, and can meet the detection requirement of tumor markers on the market; the human plasma is used as the matrix liquid raw material, and the treated components are substantially consistent with the serum, thereby minimizing the matrix effect; the invention is tested The prepared composite control product has good uniformity and stability, is not affected by transportation, temperature and other factors, and has stable performance. It can be used not only for indoor quality control of multiple detection items of tumor markers, but also for inter-room quality evaluation organizers. Inter-room quality assessment activities. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111579803-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114200133-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109916682-A |
priorityDate | 2018-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 940.